Large-scale proteomics in population-based studies may contribute to a better understanding of diseases
In an article revealed in Nature, scientists from deCODE Genetics, a subsidiary of the pharmaceutical company Amgen, demonstrated how plasma proteomics can contribute to a better understanding of diseases.